These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975 [TBL] [Abstract][Full Text] [Related]
4. Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin. Fager G; Camejo G; Bondjers G In Vitro Cell Dev Biol; 1992 Mar; 28A(3 Pt 1):168-75. PubMed ID: 1582991 [TBL] [Abstract][Full Text] [Related]
5. Heparin-binding growth factor type one and platelet-derived growth factor are required for the optimal expression of cell surface low density lipoprotein receptor binding activity in human adult arterial smooth muscle cells. Chen JK; Hoshi H; McKeehan WL In Vitro Cell Dev Biol; 1988 Mar; 24(3):199-204. PubMed ID: 2450862 [TBL] [Abstract][Full Text] [Related]
7. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Marikovsky M; Breuing K; Liu PY; Eriksson E; Higashiyama S; Farber P; Abraham J; Klagsbrun M Proc Natl Acad Sci U S A; 1993 May; 90(9):3889-93. PubMed ID: 8483908 [TBL] [Abstract][Full Text] [Related]
8. Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin-binding (acidic and basic fibroblast) growth factor gene expression in human vascular smooth muscle cells. Winkles JA; Gay CG Cell Growth Differ; 1991 Nov; 2(11):531-40. PubMed ID: 1726053 [TBL] [Abstract][Full Text] [Related]
9. Production of mitogenic factor(s) by ovine corpora lutea throughout the estrous cycle. Grazul-Bilska AT; Redmer DA; Killilea SD; Kraft KC; Reynolds LP Endocrinology; 1992 Jun; 130(6):3625-32. PubMed ID: 1375905 [TBL] [Abstract][Full Text] [Related]
10. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels. Mioh H; Chen JK J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412 [TBL] [Abstract][Full Text] [Related]
11. Heparin-binding (fibroblast) growth factors type one and two genes are co-expressed in proliferating normal human vascular endothelial and smooth muscle cells in culture. Mansson PE; Malark M; Sawada H; Kan M; McKeehan WL In Vitro Cell Dev Biol; 1990 Feb; 26(2):209-12. PubMed ID: 1690207 [TBL] [Abstract][Full Text] [Related]
12. Production of heparin-binding angiogenic factor(s) by bovine corpora lutea during pregnancy. Grazul-Bilska AT; Reynolds LP; Slanger WD; Redmer DA J Anim Sci; 1992 Jan; 70(1):254-62. PubMed ID: 1374752 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Kuwabara K; Ogawa S; Matsumoto M; Koga S; Clauss M; Pinsky DJ; Lyn P; Leavy J; Witte L; Joseph-Silverstein J Proc Natl Acad Sci U S A; 1995 May; 92(10):4606-10. PubMed ID: 7538678 [TBL] [Abstract][Full Text] [Related]
14. Macrophages secrete a heparin-binding inhibitor of endothelial cell growth. Besner GE; Klagsbrun M Microvasc Res; 1991 Sep; 42(2):187-97. PubMed ID: 1719354 [TBL] [Abstract][Full Text] [Related]
17. Growth factor effects on cells of the vascular wall: a survey. D'Amore PA; Smith SR Growth Factors; 1993; 8(1):61-75. PubMed ID: 7680568 [TBL] [Abstract][Full Text] [Related]
18. Initial characterization of endothelial mitogens produced by bovine corpora lutea from the estrous cycle. Grazul-Bilska AT; Redmer DA; Killilea SD; Zheng J; Reynolds LP Biochem Cell Biol; 1993; 71(5-6):270-7. PubMed ID: 7506042 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318 [TBL] [Abstract][Full Text] [Related]
20. Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells. Sawada H; Kan M; McKeehan WL In Vitro Cell Dev Biol; 1990 Feb; 26(2):213-6. PubMed ID: 2312505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]